MAPK inhibition and growth hormone: a promising therapy in XLH.
Fuente R, Gil-Peña H, Claramunt-Taberner D, Hernández-Frías O, Fernández-Iglesias Á, Alonso-Durán L, Rodríguez-Rubio E, Hermida-Prado F, Anes-González G, Rubio-Aliaga I, Wagner C, Santos F.
Fuente R, et al. Among authors: santos f.
FASEB J. 2019 Jul;33(7):8349-8362. doi: 10.1096/fj.201802007R. Epub 2019 Apr 11.
FASEB J. 2019.
PMID: 30974062
., Fernandez-Iglesias, A., Alonso-Duran, L., Rodriguez-Rubio, E., Hermida-Prado, F., Anes-Gonzalez, G., Rubio-Aliaga, I., Wagner, C., Santos, F. ...
., Fernandez-Iglesias, A., Alonso-Duran, L., Rodriguez-Rubio, E., Hermida-Prado, F., Anes-Gonzalez, G., Rubio-Aliaga, I., Wagner, C., …